Latex Agglutination Test Kits Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Latex Agglutination Test Kits Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Latex Agglutination Test Kits Market

The latex agglutination test kits market size was valued at USD 447.2 million in 2021, and the market is now projected to grow from USD 462.4 million in 2022 to USD 620.0 million by 2029, exhibiting a CAGR of 4.3% during the forecast period of 2022-2029.

There was a slight positive influence because of increases in certain tests conducted during the pandemic. The disruptions in the supply chain pandemic represented an impulsive situation for equipment manufacturers. The reduced capacities of hospitals for the diagnosis of other diseases affect the market growth. However, diagnosis of other disorders has augmented because of the recovery of medical services and smoothness in the supply of testing kits. Hence, the COVID-19 pandemic has impelled the latex agglutination test kits market growth.

The latex agglutination test kits market share globally has increased as a consequence of the growing diverse application areas of these tools. Usage of these kits for the analysis of a range of infectious and autoimmune diseases increased demand for the product. Some studies have been performed to evaluate the efficacy and specificity of these testing kits. Such clinical studies offer a scientific basis regarding the effectiveness of these tools and favoring their adoption in the market.

The trend is adoption of Point of Care (POC) techniques/ rapid diagnostics for infectious and autoimmune diseases propelling the market growth. These test kits are included under POC and rapid diagnostics. It requires a small amount of samples for detection. These products are easy to standardize and provide quick results. Additionally, the rising pervasiveness of infectious and autoimmune diseases has caused increased disease and an economic burden. These kits are sustainable and cost-efficient, thus easily accessible in emerging nations.

Comprehensive Analysis of Latex Agglutination Test Kits Market

The latex agglutination test kits market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by test type, sample type, and end user. The types of tests involve antibody detection and antigen testing (Escherichia coli, staphylococcus aureus, streptococcus, and others). The sample types include blood, urine, cerebrospinal fluid (Lumbar punctures), and others. The end-users are hospital-based laboratories and standalone clinical laboratories.

The North American region is conducive to the global latex agglutination test kits market, leading to a recall of USD 203.5 million owing to diverse application areas of these kits in various diseases and the existence of major operating players in this region.

The top players in the market play a vital role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include Atlas Medical GmbH (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), HiMedia Laboratories (India), Pro Lab Diagnostics Inc. (Canada), Arlington Scientific, Inc. (U.S.), Hardy Diagnostics (U.S.), Liofilchem S.r.l. (Italy), and Biotec (Novacyt) (U.K.), these market players provide a level-playing competitive landscape.

In July 2022, Bio-Rad Laboratories, Inc. unveiled two products, the Synthetic Negative Run Control for tick-borne, meningitis/encephalitis, and sexually-transmitted infections products, and HAI Negative Run Control for hospital-associated infections products.

Segmentation Table

Global Latex Agglutination Test Kits Market Scope

ATTRIBUTE

DETAILS

Study Period

2018-2029

Base Year

2021

Estimated Year

2022

Forecast Period

2022-2029

Historical Period

2018-2020

Unit

Value (USD million)

Segmentation

By Test Type, Sample Type

, End-user, and Region

By Test Type

Antibody Detection

Antigen Testing

• Streptococcus
• Staphylococcus Aureus
• Escherichia Coli
• Others

By Sample Type

Blood

Urine

Cerebrospinal Fluid (Lumbar Puncture)

Others

By End-user

Hospital-based Laboratories

Standalone Clinical Laboratories

By Region

North America (By Test Type, By Sample Type, By End-user, and By Country)

U.S.

Canada

Europe (By Test Type, By Sample Type, By End-user, and By Country/Sub-Region)

U.K.

Germany

France

Italy

Spain

Scandinavia

Rest of Europe

Asia Pacific (By Test Type, By Sample Type, By End-user, and By Country/Sub-Region)

Japan

China

India

Australia

Southeast Asia

Rest of Asia Pacific

Rest of the World (By Test Type, By Sample Type, and By End-user)Please Note: It will take 5-6 business days to complete the report upon order confirmation.